Page last updated: 2024-09-03

octanoylcarnitine and HIV Coinfection

octanoylcarnitine has been researched along with HIV Coinfection in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aukrust, P; Berge, RK; Damås, JK; Flo, TH; Landrø, L; Svardal, A; Ueland, T; Waagsbø, B; Øktedalen, O	1

Other Studies

1 other study(ies) available for octanoylcarnitine and HIV Coinfection

Article	Year
Low levels of short- and medium-chain acylcarnitines in HIV-infected patients. European journal of clinical investigation, 2016, Volume: 46, Issue:5 Topics: Adult; Antiretroviral Therapy, Highly Active; Carnitine; Case-Control Studies; Disease Progression; Female; HIV Infections; Humans; Interferon-gamma; Interferon-gamma Release Tests; Longitudinal Studies; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Tumor Necrosis Factor-alpha	2016

Article

Year

Low levels of short- and medium-chain acylcarnitines in HIV-infected patients.

European journal of clinical investigation, 2016, Volume: 46, Issue:5

Topics: Adult; Antiretroviral Therapy, Highly Active; Carnitine; Case-Control Studies; Disease Progression; Female; HIV Infections; Humans; Interferon-gamma; Interferon-gamma Release Tests; Longitudinal Studies; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Tumor Necrosis Factor-alpha

2016